Article
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Mar 2013
Friso Simonetta, Udali Silvia, Guarini Patrizia, Pellegrini Camilla, Pattini Patrizia, Moruzzi Sara, Girelli Domenico, Pizzolo Francesca, Martinelli Nicola, Corrocher Roberto, Olivieri Oliviero, Choi Sang-Woon
Abstract excerpt
BACKGROUND: Global DNA hypomethylation is an early molecular event in carcinogenesis. Whether methylation measured in peripheral blood mononuclear cells (PBMCs) DNA is a clinically reliable biomarker for early detection or cancer risk assessment is to be established. METHODS: From an original sample-set of 753 male and female adults (ages 64.8 ± 7.3 years), PBMCs DNA methylation was measured in 68 subjects with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
